{"id":"NCT01158378","sponsor":"HyperBranch Medical Technology, Inc","briefTitle":"Safety and Effectiveness of the Adherus Dural Sealant System When Used as a Dural Sealant in Cranial Procedures","officialTitle":"A Pivotal Clinical Trial Examining the Safety and Effectiveness of the Adherus Dural Sealant System When Used as a Dural Sealant in Cranial Procedures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2010-07-08","resultsPosted":"2014-04-08","lastUpdate":"2014-04-08"},"enrollment":250,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Elective Cranial Procedures With Dural Incision"],"interventions":[{"type":"DEVICE","name":"Adherus Dural Sealant","otherNames":[]}],"arms":[{"label":"DuraSeal Dural Sealant System","type":"ACTIVE_COMPARATOR"},{"label":"Adherus Dural Sealant System","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to demonstrate the safety and effectiveness of the Adherus Dural Sealant System when used as a dural sealant in conjunction with standard methods of dural repair in cranial procedures.","primaryOutcome":{"measure":"Proportion of Treated Subjects Who Were Free of Intra-operative Cerebrospinal Fluid (CSF) Leakage From Dural Repair During Valsalva Maneuver, CSF Leak / Pseudomeningocele, and Unplanned Retreatment of the Original Surgical Site","timeFrame":"120 days","effectByArm":[{"arm":"Adherus Dural Sealant System","deltaMin":91.2,"sd":null},{"arm":"DuraSeal Dural Sealant System","deltaMin":90.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0049"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":5},"locations":{"siteCount":17,"countries":["United States"]},"refs":{"pmids":["23344862"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":124},"commonTop":["Headache","Vision Blurred","Hypoaesthesia","Dizziness"]}}